Virtu Financial’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Virtu Financial’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-12,155	Closed	-$219K	–	1797
2020 Q2	$219K	Buy	+12,155	New	+$169K	0.03%	681
2019 Q4	$207K	Buy	8,681 +369	+4%	+$10.2K	0.02%	918
2019 Q3	$223K	Buy	+8,312	New	+$233K	0.02%	907
2018 Q4	–	Sell	-9,239	Closed	-$246K	–	2167
2018 Q3	$246K	Buy	9,239 +27	+0.3%	+$882	0.02%	966
2018 Q2	$348K	Buy	+9,212	New	+$352K	0.02%	1047
2018 Q1	–	Sell	-12,188	Closed	-$593K	–	2914
2017 Q4	$593K	Buy	12,188 +6,130	+101%	+$310K	0.03%	717
2017 Q3	$327K	Buy	+6,058	New	+$356K	0.02%	1305

Virtu Financial's PTLA Position: Q3 2020 in Review

Virtu Financial sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 12,155 shares — an estimated $219K sold.

Virtu Financial first reported a position in PTLA in Q3 2017 and held it in 7 quarters. The position peaked at $593K in Q4 2017. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

Virtu Financial reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Virtu Financial sold 12,155 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $219K.
Virtu Financial first reported a position in Portola Pharmaceuticals, Inc. in Q3 2017 and held it in 7 quarters.
Virtu Financial's Portola Pharmaceuticals, Inc. position peaked at $593K in Q4 2017.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Virtu Financial's 13F filing for Q3 2020, filed 11 Dec 2020.